Overview
- The RIVM's nationwide study, published Wednesday, July 1, tested 1,629 breast‑milk samples and detected PFAS in every sample with about 18 percent exceeding a defined risk threshold.
- Health bodies and lactation experts continue to advise mothers to breastfeed because its known benefits outweigh the uncertain risks from current PFAS levels.
- Scientists link long‑term PFAS exposure to weakened immune response, higher cholesterol, liver damage and some cancers while noting detection in milk alone does not predict immediate illness in infants.
- Policymakers in the Netherlands are working with other EU countries on a proposal to restrict roughly 10,000 PFAS, a measure officials expect to take effect in about two years.
- Early mitigation research — including trials of soluble fiber, blood donation and statins — and commercial PFAS testing exist but are still too preliminary to change official breastfeeding guidance.